Catalyst Wire Dossier Catalyst Wire Dossier

Carfilzomib (Kyprolis)

carfilzomib · Amgen
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Carfilzomib (Kyprolis), covering 2014-11-20 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma [Phase 2]

See pricing